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ABstrAct - Background: cerebral salt wasting syndrome (csWs), syndrome of inappropriate antid-
iuretic hormone secretion (sIADH) and diabetes insipidus (DI) are frequently found in postoperative 
neurosurgery.  Purpose: to identify these syndromes following neurosurgery.  Method: the study in-
cluded 30 patients who had been submitted to tumor resection and cerebral aneurysm clipping. sodium 
levels in serum and urine and urine volume were measured daily up to the 5th day following surgery. Plas-
ma arginine vasopressin (AVP) was measured on the first, third and fifth days post-surgery.  Results: csWs 
was found in 27/30 patients (90%), in 14 (46.7%) of whom it was associated with a reduction in the levels 
of plasma AVP (mix syndrome). sIADH was found in 3/30 patients (10%). there was no difference between 
the two groups of patients.  Conclusion: csWs was the most common syndrome found, and in half the 
cases it was associated with DI. sIADH was the least frequent syndrome found. 
Key WorDs: cerebral salt wasting syndrome, syndrome of inappropriate antidiuretic hormone secretion, 
diabetes insipidus, mixed syndrome, neurosurgery.
Síndromes relacionadas com alterações de sódio e arginina-vasopressina no pós-operatório de 
neurocirurgia
resUMo - Introdução: A síndrome perdedora de sal (sPs), síndrome da secreção inapropriada do hormô-
nio antidiurético (sIADH) e diabetes insipidus (DI) são freqüentemente encontradas no pós-operatório de 
neurocirurgia.  Objetivo: Identificar essas síndromes relacionadas à neurocirurgia.  Método: Foram estu-
dados 30 pacientes submetidos à ressecção de tumor (n=19) e clipagem de aneurisma (n=11) cerebral du-
rante os primeiros cinco dias do pós-operatório. os pacientes foram submetidos a dosagens diárias de só-
dio sérico e urinário até o 5º dia pós-operatório, com controle de volume urinário neste período e dosa-
gem de arginina-vasopressina (AVP) plasmática no 1º, 3º e 5º dias pós-operatórios.  Resultados: A sPs foi 
encontrada em 27/30 pacientes (90%), em 14/27 (46,7%) associada à diminuição dos níveis de AVP plasmá-
tica (síndrome mista). A sIADH foi encontrada em 3/30 pacientes (10%). Não houve diferença entre os dois 
grupos de pacientes.  Conclusão: A sPs foi a síndrome mais freqüente, em metade de casos associada ao 
DI. A sIADH foi a menos freqüente. 
PAlAVrAs-cHAVe: síndrome perdedora de sal, síndrome de secreção inapropriada de hormônio antidiu-
rético, diabetes insipidus, síndrome mista, neurocirurgia.
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Alterations in sodium are frequently found in 
neurological and neurosurgical patients1-7 and are 
associated with alterations in the osmolarity of the 
extracellular medium and changes in the volume of 
the cells of the central nervous system (cNs). they 
may aggravate the condition of these patients8. 
Hyponatremia is the sodium disturbance most fre-
quently found in patients with severe cerebral dam-
age occurring in 29-33% of patients following sub-
arachnoid hemorrhage (sAH)9-12. Initially, hyponatre-
mia in patients with intracranial disease was attrib-
uted to cerebral salt wasting syndrome (csWs), as 
proposed by Peters et al. in 195013. later, the syn-
drome of inappropriate antidiuretic hormone secre-
tion (sIADH), described by schwartz et al. in 195714, 
became accepted as the principal cause of hypona-
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tremia in neurological patients with excessive uri-
nary sodium loss, and the original concept of csWs 
was abandoned1,8,14-17. Hypernatremia is the sodium 
disturbance least frequently found in these patients 
and its principal cause is neurogenic diabetes insipi-
dus. Improved knowledge with respect to the phys-
iology of arginine vasopressin (AVP), the possibility 
of its measuring by radioimmunoassay2,16-21 and the 
report of hypovolemia in the majority of neurologi-
cal patients presenting hyponatremia and natriuresis, 
led investigators to question sIADH in brain disease. 
Many questions remain unanswered with respect to 
sIADH since few studies in which AVP was measured 
have been reported and results have been contradic-
tory1,2,7. At the present time, csWs has again been 
proposed as a cause of hyponatremia associated with 
neurological disease. the majority of patients diag-
nosed with sIADH are hypovolemic and, when treat-
ed with fluid restriction, may develop a stroke with 
consequent worsening of their neurological condi-
tion18, suggesting that csWs may be the most proba-
ble cause of hyponatremia in these patients1,2,4,5,7,16,19. 
other studies suggest that hyponatremia may be iat-
rogenic, secondary to the excessive administration of 
hypotonic liquids20.
csWs and sIADH show very similar laboratory 
characteristics13-15 and are equally associated with 
neurological disease. However, they differ with re-
spect to volemic states since sIADH is associated with 
normovolemia or hypervolemia, whereas csWs is as-
sociated with fluid depletion2,4,5,7. Although sIADH 
is characterized by fluid retention, the majority of 
Table 1. Demographic data, pre- and postoperative Glasgow Coma Scale score and neurologic diagnoses in patients of Group A and B. 
Patient Age 
(years)





A1 62 M W 15 15 tumor of the posterior fossa 
A2 37 M W 15 15 Frontal tumor 
A3 25 F W 15 15 orbital tumor 
A4 47 F M 15 14 left sphenoidal meningoma
A5 17 F W 15 15 left temporal tumor 
A6 16 M W 12 15 cerebellar tumor 
A7 26 F W 15 Death Intraventricular tumor
A8 39 F W 15 15 Meningoma
A9 46 M W 15 15 left frontal-parietal tumor
A10 68 F M 15 15 central frontal meningoma
A11 65 M W sedated Death right frontal meningoma 
A12 60 F W 14 15 right frontal tumor
A13 48 M W 15 15 Middle fossa tumor 
A14 59 F W 15 Death left multiforme glioblastoma 
A15 68 M W 15 15 cerebellar tumor 
A16 45 F W 14 15 left temporal meningoma 
A17 77 M W 15 15 right parietal tumor 
A18 51 F N 15 15 left posterior fossa meningoma 
A19 19 M W 15 15 Glomus jugular tumor 
B1 16 F N 15 15 Malformation left frontal stroke
B2 45 F W 11 11 Anterior communicating artery  aneurysm
B3 48 F M 15 15 Anterior communicating artery  aneurysm
B4 46 M M 10 Death Anterior communicating artery aneurysm
B5 70 F W 15 15 Anterior communicating artery aneurysm
B6 78 F W 14 15 Posterior communicating artery aneurysm
B7 46 M W 15 Ischemic stroke Anterior communicating artery aneurysm
B8 39 M W 15 15 Aneurysm at the top of the basilar artery
B9 36 F W 15 15 right middle cerebral artery aneurysm
B10 30 F W 15 15 left middle cerebral artery aneurysm
B11 15 M W 15 15 Anterior communicating artery aneurysm
M, male; F, female; op, operatory; W, white; M, mulatto; N, negro. 
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Table 2. Alterations used in the differential diagnosis of syndromes responsible for so-
dium disturbances found in the postoperative phase of patients in this study.  
csWs sIADH DI
Fluid balance ↓ Normal or ↑ ↓
Volume of urine ↑ Normal or ↓ ↑
serum sodium ↓ ↓ ↑
Urinary sodium ↑ ↑ Normal
Plasma AVP Normal ↑ ↓
↓ decrease; ↑ increase.
patients show no signs of hypervolemia since one-
third of the remaining fluid is maintained in the ex-
tracellular compartment, making diagnosis difficult8. 
Measurement of AVP can be useful in the differen-
tial diagnosis of these syndromes2,7. However, it can 
also be influenced by several factors involved in the 
postoperative phase of neurosurgical patients, that 
are able to stimulate the non-osmotic secretion of 
AVP, such as stress, an increase in intracranial pres-
sure (IcP), pain, use of medication (antipsychotics, tri-
cyclic antidepressives, carbamazepine, morphine, an-
esthetics, metoclopramide), hypovolemia, prolonged 
recumbency and positive-pressure mechanical venti-
lation4,7,16,22-27. considering that patients submitted 
to neurosurgery may frequently suffer sodium and 
AVP alterations of various causes and since differen-
tial diagnosis of these alterations is essential to guar-
antee adequate treatment, their accurate diagnosis 
is of great importance17,18.
the objective of the present study is therefore to 
identify the presence of syndromes related to sodium 
alterations occurring in neurological patients during 
the postoperative period.
METhOD
the study was carried out at the teaching Hospital of 
the state University of campinas (UNIcAMP), Brazil. It was 
approved by the Internal review Board under protocol 
number 142/99. signed, informed consent was obtained 
from the patients themselves or from their next-of-kin pri-
or to admission to the study.
thirty consecutive patients (males and females) over 13 
years of age, who had been submitted to craniotomy either 
for resection of a brain tumor (Group A, n=19) or for clipping 
of an aneurysm of the cerebral artery (Group B, n=11) were 
enrolled to the study. the groups of patients were consid-
ered homogenic with respect to the parameters of age, sex, 
race, and the pre- and postoperative Glasgow coma scale 
(Gcs) scores, (table 1). sodium measurements in serum and 
urine (12 hour, overnight urine) were carried out on post-
operative days 1-5 (D1-D5), urinary volume was measured in 
the 12-hour overnight period and plasma arginine vasopres-
sin (AVP) measurements were carried out by radioimmuno-
assay on postoperative days 1, 3 and 5 (D1, D3, D5).
Table 3. Plasma arginine vasopressin values on the 1st, 2nd and 
3rd postoperative days in patients of Groups A and B 
Patient D1 D3 D5
A1 27,5 1,1 2,0
A2 0.9 0.5 0.7
A3 0.7 0.5 0.4
A4 2.4 0.4 0.4
A5 <0.15 0,7 NM
A6 <0.15 <0.15 0.6
A7 0.7 1.2 Dead
A8 0.9 0.5 <0.15
A9 1.3 1.0 NM
A10 2.6 1.9 2.2
A11 1.3 0.8 0.7
A12 0.6 1.1 NM
A13 0.4 <0.15 0.8
A14 0.7 0.5 0.7
A15 0.3 1.0 0.5
A16 0.4 0.2 0.3
A17 0.15 <0.15 NM
A18 0.75 1.4 NM
A19 1.7 1.3 1.4
B1 0.9 0.9 0.7
B2 1.2 1.2 0.9
B3 2.4 0.4 0.6
B4 1.3 8.2 Dead
B5 0.6 <0.15 0.7
B6 8.5 2.0 0.5
B7 0.8 0.3 0.5
B8 0.8 0.6 0.15
B9 0.4 0.6 0.6
B10 2.5 1.8 NM
B11 1.7 1.2 NM
Normal value of plasma AVP: 0.5-5.0 pg/ml; NM, not measurable.
Patients received a minimum volume of 30 ml/kg of 
0.9% Na cl per day during the postoperative period. central 
venous blood pressure was maintened above 10 mmHg.
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exclusion criteria included: age <13 years, pregnan-
cy, diagnosis of hypophyseal tumor and previously diag-
nosed alterations in cardiac, renal, adrenal, thyroid or he-
patic function.
Diagnostic criteria used for related syndromes are 
shown in table 2.
the Mann-Whitney test was used in the statistical anal-
ysis of the comparison of continuous measurements be-
tween the two groups and the chi-square test or Fisher’s 
exact test were used for the comparison of proportions. 
significance was established at 5% .
RESULTS
Hydro-electrolytic and plasma AVP alterations 
– Plasma AVP levels are shown in table 3. table 4 
shows the occurrence of alterations in sodium, uri-
nary volume and plasma AVP for each patient. these 
alterations, permitted a differential diagnosis of the 
syndromes (csWs, sIADH, DI), based on the diagnos-
tic criteria already described in table 2.
Distribution of syndromes according to group 
– there were no statistically significant differences 
in the distribution of syndromes between the two 
groups (p=0.7737), as shown in table 5. this allowed 
us to group them into one single set, showing that of 
the 30 patients in the study, 27 developed csWs, of 
which 13/27 developed csWs alone and 14/27 devel-
oped csWs associated with DI (mixed syndrome); in 
Table 4. Alterations in sodium, natriuresis, urinary volume and plasma AVP found in patients of both groups with the respective 
diagnoses of the syndromes involved.
Patient Hyponatremia Hypernatremia Natriuresis Polyuria ↑ AVP ↓ AVP Diagnosis
A1 X X X X sIADH
A2 X X csWs
A3 X X X csWs + DI
A4 X X X X csWs + DI
A5 X X X csWs + DI
A6 X X X X csWs + DI
A7 X X X csWs
A8 X X X X csWs + DI
A9 X X X csWs
A10 X X X csWs
A11 X X X csWs
A12 X X csWs
A13 X X X X csWs + DI
A14 X X X X csWs
A15 X X X X csWs + DI
A16 X X X X csWs + DI
A17 X X X csWs + DI
A18 X X X csWs
A19 X X csWs
B1 X X csWs
B2 X X X csWs
B3 X X X csWs + DI
B4 X X X sIADH
B5 X X X X csWs + DI
B6 X X X sIADH
B7 X X X csWs + DI
B8 X X X X csWs + DI
B9 X X X csWs + DI
B10 X X X csWs
B11 X X X csWs
Hyponatremia=serum sodium <135meq/l; hypernatremia=serum sodium >145 meq/l; Natriuresis=urinary sodium >110 meq/12h; polyuria=urinary vol-
ume >1050 ml/12h; normal AVP=0.5-5.0 pg/ml; X-present; ↓ decrease;  ↑ increase.
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this period no patient developed DI on its own and 
three presented sIADH.
DIScUSSION
Hyponatremia in neurological and neurosurgical 
patients can occur secondary to cerebral salt wast-
ing syndrome10,13,18,28 or syndrome of inappropriate 
antidiuretic hormone secretion15 and iatrogenically 
as a result of a large infusion of hypotonic liquid20. In 
this study, no patient received hypotonic liquid in ex-
cess, and sodium and fluid replacement were carried 
out whenever necessary. therefore, hyponatremia, 
present in 19/30 patients (63.3%) in the postopera-
tive phase, must not have occurred iatrogenically but 
must have been secondary to csWs or sIADH.
the most common cause of hypernatremia in neu-
rological patients is diabetes insipidus and this con-
dition may also occur iatrogenically or secondary to 
neurological lesions. the most common form of dia-
betes insipidus is that wich folows trauma or surgery 
to the region of the pituitary and hypothalamus29. As 
we excluded patients with pituitary tumor there were 
no patients with isolated diabetes insipidus. Diabetes 
insipidus may exibit as three patterns: transient, per-
manent and triphasic. the triphasic patern is observed 
more often clinicaly. First, a polyuric phase occurs and 
lasts 4-5 days. 
Inhibition of ADH causes the polyuric phase. sec-
ond, an antidiuretic phase of 5-6 days occurs, with 
results from release of stored hormone and the third 
phase can be permanent DI, when stores of ADH are 
exausted and the cells that produce more ADH are 
absent or unable to produce. 
In this study, hypernatremia was observed iatro-
genically in 2/30 patients (6.7%) due to the adminis-
tration of hypertonic liquid and because of the excess 
correction of hyponatremia. No patient presented 
hypernatremia associated with low levels of AVP.
Urine sodium loss (natriuresis) can be caused by 
csWs or sIADH and most studies show that its most 
probable cause is csWs, natriuresis being preceded 
by hyponatremia and not correlated to AVP. this sug-
gests that csWs is the principal cause of natriuresis in 
these patients2,10,30. the present study also shows that 
most of the patients who developed hyponatremia 
and natriuresis presented no increase in plasma AVP 
levels, suggesting that the probable cause of natri-
uresis in these patients is csWs. 
Increased plasma levels of AVP occur due to sI-
ADH. However, most studies show that in the imme-
diate postoperative period and in the initial stages of 
sAH, the increase in AVP may be attributed to surgi-
cal stress, increased IcP, use of medication (metochlo-
pramide, morphine, anticonvulsants), pain and/or loss 
of blood during surgery, and not to sIADH2,10,20,27,28. 
some authors also suggest the participation of AVP 
in csWs. this hypothesis suggests that hypovolemia 
stimulates AVP secretion in a physiologically correct 
manner despite the suppressive effect of hyponatre-
mia on AVP, and that in sIADH the increase in AVP 
occurs inappropriately since there is an expansion in 
the actual vascular volume.
In this study, increased plasma AVP measurements 
(>5.0 pg/ml) were found in only 3/30 patients (10%), 
and 3/150 measurements at the first posoperatory 
day. considering that none of these patients devel-
oped hypovolemia, which could have justified the 
increase in AVP, the cause may be due to sIADH or to 
the physiological response to surgical stress.
Decreased plasma levels of AVP (<0.5 pg/ml) were 
found in 14/30 patients (46.7%), in 23 of 150 mea-
surements during the postoperative period. the most 
common cause of the reduction in plasma secretion 
of AVP in neurological patients is hyponatremia or 
secondary to neurological lesions .
In this study, the reduction in the plasma levels of 
AVP was associated with hyponatremia. However, all 
patients also presented csWs concomitantly and re-
duction in the plasma levels of AVP thereby prevent 
the patients from developing higher hyponatremia. 
It was also observed that, in the postoperative phase, 
27/30 patients (90%) developed cerebral salt wast-
ing syndrome, 13 of these (43.3%) developing csWs 
alone and 14/27 (46.7%) developing csWs associated 
Table 5. Distribution of syndromes between the groups. 
csWs csWs + DI DI sIADH
Group A 9 9 0 1
Group B 4 5 0 2
total 13 14 0 3
% 43.3 46.7 0 10
Fisher’s exact test (p=0.7737).
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with diabetes insipidus (mixed syndrome). three out 
of thirty patients (10%) suffered an increase in plas-
ma AVP levels. there was no statistically significant 
difference in the distribution of syndromes between 
the two groups (p=0.7737), which allows us to ana-
lyze them as a single set.
the incidence of csWs among all the patients was 
greater than that of sIADH, which is in agreement 
with reports from various other authors, who also 
observed a greater prevalence of csWs, compared 
to sIADH in neurological patients1,2,4,5,10,18,30. the co-
existence of DI and csWs (mixed syndrome) observed 
in our patients has also been described by yamaki 
et al.17, who studied two patients postoperatively 
following surgery for pituitary tumor and observed 
the presence of severe natriuresis and hyponatre-
mia in a study patient who developed DI (fluid loss 
>2.36 ml/kg/h), which led the authors to conclude 
that hyponatremia resulting from csWs in intracra-
nial diseases may develop in patients with DI. simi-
lar findings were described by laredo et al.29, who 
reported hypernatremia resulting from DI, followed 
by hyponatremia due to sodium urinary loss compat-
ible with csWs, in the immediate postoperative pe-
riod of two neurosurgical patients. However, plasma 
measurements of AVP were not carried out in either 
of these studies.
studies reported in the literature about the altera-
tions in hydro-electrolytic control and the syndromes 
responsible for these disturbances are mostly case re-
ports and retrospective studies. these studies include 
small, diverse populations and analyze few variables 
using a variety of methods. Few studies have been 
carried out using a control group and their results 
are conflicting. In these studies, the differential diag-
nosis between csWs and sIADH is based on volemic 
state, as measured by indirect, insufficient methods 
with no comparative studies between the different 
methods. Also, in the majority of studies on csWs in 
a group of patients, examples are cited but there are 
no group values.
In the present study, difficulty was found in con-
trolling the water and sodium balance in patients 
spontaneously ingesting liquids. otherwise, addi-
tional data could have been available, particularly 
in the case of those patients who developed csWs 
associated with DI, justifying the association of these 
syndromes. since the patients with csWs are hypovo-
lemic and volemic state is the most potent stimulus 
of AVP secretion, levels of the latter should be high. 
However, in this study, osmotic stimulus apparently 
prevailed over volemic state, leading to a fall in AVP 
in patients with csWs. the doubt remains regarding 
whether the decrease in AVP associated with csWs 
can be considered a compensatory mechanism or a 
“protector” of plasma sodium, increasing the loss of 
free water. this compensatory mechanism may in-
crease fluid loss even further, which could be harm-
ful to these patients. this fluid loss may indeed be 
compensatory and “protective” in the attempt to re-
duce the cerebral edema and intracranial hyperten-
sion that may be caused by the severe hyponatremia. 
In this case, a cerebral natriuretic factor may be in-
volved in the physiopathology of csWs, as suggested 
by some authors7,29,30.
there are no large studies reported in the litera-
ture on csWs alone or in association with DI (mixed 
syndrome); neither are there studies on the participa-
tion of intracranial pressure (IcP) in the hydro-elec-
trolytic imbalance of the syndromes involved. Un-
fortunately, in our study, IcP was also not routinely 
monitored. therefore, additional studies are required 
to provide more data on the association of cerebral 
salt wasting syndrome with diabetes insipidus, the in-
fluence of intracranial pressure in hydro-electrolytic 
control, on the role of the atrial natriuretic factor 
and the possible existence of a brain natriuretic fac-
tor, involved in the pathophysiology of cerebral salt 
wasting syndrome.
In conclusion, in this study cerebral salt wasting 
syndrome was the syndrome most frequently found, 
being detected in 90% of cases, and was associated 
most often with diabetes insipidus (46.7%) (mixed 
syndrome). Diabetes insipidus was not found alone 
in any of our patients. syndrome of inappropriate 
antidiuretic hormone secretion was found less fre-
quently (10%) and may be merely a response to sur-
gical stress. there was no difference between the 
two groups studied (cerebral tumor resection and 
clipping of cerebral artery aneurysm) in the incidence 
of the three syndromes. An adequate diagnosis is 
very important in defining treatment, reducing the 
complications and mortality related to the inade-
quate management of sodium disturbances during 
the neurological postoperative phase.
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